Poland· PL-100220572
Bespres
A valsartan product containing valsartanum, registered in Poland by Teva Pharmaceuticals Polska Sp. z o.o.. The same ATC class is registered in 19 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Valsartan is registered in 19 of 19 countries.
Countries holding a registration under ATC C09CA03 (valsartan), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Valsartan · ATC C09CA03
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of valsartan costs, country by country.
Normalised to the WHO defined daily dose (80 mg), the median price runs from $0.14 in France to $0.56 in Switzerland — a ×4.1 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Valsartan · price per daily dose (80 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.56
- IT Italy$0.15
- FR France$0.14
The record
At a glance
URPL (Poland)- Active substance
- Valsartanum
- Manufacturer
- Teva Pharmaceuticals Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- C09CA03
- ATC class
- Valsartan
- Defined daily dose
- 80 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 13
1 priced- gtin05909990751587
- gtin05909990751686
- gtin05909990751693
- gtin05909990751709
- gtin05909990751723
- gtin0590999075159428 szt.PLN 13.56
- gtin05909990751655
- gtin05909990751662
- gtin05909990751679
- gtin05909990751600
- gtin05909990751624
- gtin05909990751631
- gtin05909990751648
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
421 interactions on record for valsartan.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Valsartan · interactions on record
421 records
- 7 severe
- 128 moderate
- 205 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium gluconateA12BA05severe
- Potassium chlorideB05XA01severe
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Valsartan in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBLESSINEgis Pharmaceuticals PLC, Budapešť
- SpainARALTER 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Alter S.A.
- United StatesValsartanNorthwind Health Company, LLC
- FinlandDiovanNovartis Finland Oy
- BelgiumCo-Diovane 80 mg - 12.5 mgPI Pharma
- SwedenAngiosan 80 mg Filmdragerad tablettNovartis Sverige AB
- FranceNISIS 80 mg, comprimé pelliculéNOVARTIS PHARMA
- SwitzerlandDiovan
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Diovan, Valsacor
- Belgium · Diovane, Valsartan Eg
- Bulgaria · Suvartar, Валдипин
- Cyprus · Codaval, Diovan
- Czechia · Blessin, Diovan
- Germany · Diovan, Diovan Forte
- Denmark · Diovan, Valhelen
- Estonia · Diovan, Valsacor
- Spain · Diován, Diován Cardio
- Finland · Diovan, Valsarstad
- France · Tareg, Valsartan Arrow Lab
- United Kingdom (Northern Ireland) · Diovan, Valsartan
- Greece · Avalsan, Diosartan
- Croatia · Diovan, Val
- Hungary · Diovan, Tensart
- Ireland · Diovan, Valsartan Krka
- Iceland · Diovan, Docartan
- Italy · Alsartir, Pressloval
- Lithuania · Diovan, Suvartar
- Luxembourg · Diovane, Valsartan Eg
- Latvia · Diovan, Valsacor
- Malta · Diovan, Valsaben
- Netherlands · Diovan, Exsartz
- Norway · Diovan, Valsartan Actavis
- Portugal · Diovan, Valsartan Alter
- Romania · Diovan, Valsacor
- Sweden · Angiosan, Diovan
- Slovenia · Diovan, Valsacor
- Slovakia · Diovan, Valsacor
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a9b22c2b-94fd-43c4-b26c-4c9d341281a8 GET /v1/drugs/a9b22c2b-94fd-43c4-b26c-4c9d341281a8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "80 mg",
"packaging": "05909990751587 ¦ Rp ¦ 55159\n28 tabl. (4 x 7)\n05909990751594 ¦ Rp ¦ 55160\n28 tabl. (2 x 14)\n05909990751600 ¦ Rp ¦ 55161\n30 tabl.\n05909990751624 ¦ Rp ¦ 55163\n50 tabl.\n05909990751631 ¦ Rp ¦ 55164\n56 tabl. (4 x 14)\n05909990751648 ¦ Rp ¦ 55165\n56 tabl. (8 x 7)\n05909990751655 ¦ Rp ¦ 55166\n60 tabl.\n05909990751662 ¦ Rp ¦ 55167\n84 tabl. (6 x 14)\n05909990751679 ¦ Rp ¦ 55168\n84 tabl. (12 x 7)\n05909990751686 ¦ Rp ¦ 55169\n90 tabl.\n05909990751693 ¦ Rp ¦ 55170\n98 tabl. (7 x 14)\n05909990751709 ¦ Rp ¦ 55171\n98 tabl. (14 x 7)\n05909990751723 ¦ Rp ¦ 55172\n100 tabl.",
"substance": "Valsartanum 80 mg",
"common_name": "Valsartanum",
"pl_product_id": "100220572",
"pozwolenie_nr": "16276",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about valsartan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.